Cited by 167Bacterial Identification and Susceptibility TestingAntibiotic Use and ResistanceNeutropenia and Cancer Infections

Benefits of adding a rapid pcr-based blood culture identification panel to an established antimicrobial stewardship program

Open access
MacVane, Shawn H., Nolte, Frederick S.·2016·Journal of Clinical Microbiology

Abstract

Studies have demonstrated that the combination of antimicrobial stewardship programs (ASP) and rapid organism identification improves outcomes in bloodstream infections (BSI) but have not controlled for the incremental contribution of the individual components. Hospitalized adult patients with blood culture pathogens on a rapid, multiplex PCR-based blood culture identification panel (BCID) that included 19 bacterial species, 5 Candida spp., and 4 antimicrobial resistance genes were studied over sequential time periods in a pre-post quasiexperimental study in 3 groups in the following categories: conventional organism identification (controls), conventional organism identification with ASP (AS), and BCID with ASP (BCID). Clinical and economic outcomes were compared between groups. There were 783 patients with positive blood cultures; of those patients, 364 (115 control, 104 AS, and 145 BCID) met inclusion criteria. The time from blood culture collection to organism identification was shorter in the BCID group (17 h; P < 0.001) than in the control group (57 h) or the AS group (54 h). The BCID group had a shorter time to effective therapy (5 h; P < 0.001) than the control group (15 h) or AS group (13 h). The AS (57%) and BCID (52%) groups had higher rates of antimicrobial de-escalation than the control group (34%), with de-escalation occurring sooner in the BCID group (48 h; P = 0.034) than in the AS group (61 h) or the control group (63 h). No difference between the control group, AS group, and BCID group was seen with respect to mortality, 30-day readmission, intensive care unit length of stay (LOS), postculture LOS, or costs. In patients with BSI, ASP alone improved antimicrobial utilization. Addition of BCID to an established ASP shortened the time to effective therapy and further improved antimicrobial use compared to ASP alone, even in a setting of low antimicrobial resistance rates.

Integrity signals

Registry

Crossref · 10.1128/jcm.00996-16

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
MacVane, S. H., & Nolte, F. S.
Affiliations
Medical University of South Carolina (US)
Venue
Journal of Clinical Microbiology
Published
2016-10
Volume
54
Issue
10
Pages
2455-2463
ISSN
  • 0095-1137 (ISSN-L)
  • 1098-660X
OpenAlex
W2496527871
Cited by
167
References
17
Citations by year
2026: 9 · 2025: 13 · 2024: 26 · 2023: 20 · 2022: 15 · 2021: 18 · 2020: 16 · 2019: 17 · 2018: 16 · 2017: 15 · 2016: 2
FWCI
16.47
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Microbiology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
BioFire Diagnostics
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Bacterial Identification and Susceptibility Testing
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antibiotic Use and Resistance
  • Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
Keywords
antimicrobial stewardship, blood culture identification, multiplex PCR, bloodstream infection, antibiotic de-escalation, antimicrobial use, Candida, antimicrobial resistance genes, hospital costs
MeSH terms
Blood Culture, Adolescent, Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents, Drug Utilization, Female, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Time Factors, Polymerase Chain Reaction, Bacteremia, Treatment Outcome, Young Adult, Candidemia, Non-Randomized Controlled Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review